Bilirubin Total, Serum
10
Bilirubin is a product of hemoglobin metabolism. It is created during the normal destruction process of red blood cells and is transported to the liver as a complex with serum albumin. In the liver, bilirubin is conjugated with glucuronic acid to become soluble, and is subsequently transported through the bile duct for elimination via the digestive tract.
There are three core reasons for an increase in bilirubin:
- Diseases or conditions that result in the production of bilirubin faster than the liver can metabolize it cause increases in the levels of unconjugated (indirect) bilirubin in the circulation.
- Liver immaturity and several other diseases in which the bilirubin conjugation mechanism is impaired can cause elevations of circulating unconjugated bilirubin.
- Bile duct obstruction or damage to hepatocellular structure causes increases in the levels of both conjugated (direct) and unconjugated (indirect) bilirubin in the circulation.
- In diagnosis of liver diseases/disorders
- Used to evaluate the liver function in newborns (neonatal jaundice), or other disorders that might impair liver function
- As an aid in diagnosis of biliary tract obstructive disease
- Evaluation of jaundice
- To monitor the treatment of neonatal hyperbilirubinemia therapy, usually phototherapy.
- As an aid in diagnosis of liver enzyme abnormalities such as Dubin-Johnson syndrome, Rotor syndrome, Gilbert’s syndrome, and Crigler-Najjar syndrome
Increased in:
- Acute or chronic hepatitis
- Cirrhosis
- Biliary tract obstruction
- Toxic hepatitis
- Neonatal jaundice
- Congenital liver enzyme abnormalities (Dubin-Johnson, Rotor, Gilbert, Crigler-Najjar syndromes)
- Hemolytic disorders
- In hepatotoxic drugs
| Age / Type | Premature (mg/dL) | Full-Term (mg/dL) | Premature (µmol/L) | Full-Term (µmol/L) |
| Cord | <2.0 | <2.0 | <34 | <34 |
| 0–1 day | <8.0 | 1.4–8.7 | <137 | 24–149 |
| 1–2 days | <12.0 | 3.4–11.5 | <205 | 58–197 |
| 3-5 days | <16 | 1.5-12.0 | <274 | 26-205 |
| Adults | ||||
| >5 days–60 years | 0.3–1.2 | 5–21 | ||
| 60–90 years | 0.2–1.1 | 3–19 | ||
| >90 years | 0.2–0.9 | 3–15 |
Colorimetric/Photometric
Serum (SST) or Urine (Random).
Stability
- Ambient - 24 hours
- Refrigerated - 72 hours
- Frozen - 90 days
Samples must be protected from light.
Comprehensive Metabolic Profile, Liver Profile, Direct Bilirubin, Amylase, Lipase, CBC, Direct Antiglobulin test.
1-3 days.
- Am Fam Physician. 1992 Mar;45(3):1139-48. [PMID: 1543099]
- Am Fam Physician. 2004;69:299. [PMID: 14765767]
- Clin Cornerstone. 2001;3(6):1-12. [PMID: 11501190]
- CMAJ. 2005;172:367. [PMID: 15684121]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757